Psoriatic Arthritis
📧 Sign up to get email alerts when something new happens for Psoriatic Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis
This clinical trial update reports safety findings and changes in disease symptoms for risankizumab (Skyrizi) in adults with moderate-to-sev…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Open Label Study of the Effects of Secukinumab on Nail Psoriasis and Non-Invasive Measures of Enthesitis (Phase IV) [Phase 4]
Open-label Phase IV study evaluating secukinumab for nail psoriasis and enthesitis in psoriasis patients has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: Artificial Intelligence Literacy and E-Health Literacy in Rheumatic Diseases
A completed clinical trial evaluating artificial intelligence literacy and e-health literacy in people with rheumatic diseases, including rh…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Clinical Study of Efficacy and Safety of BCD-085 (Monoclonal Anti-IL-17 Antibody) in Psoriatic Arthritis [Phase 3]
Biocad's monoclonal anti-IL-17 antibody BCD-085 completed a Phase 3 study evaluating efficacy and safety in psoriatic arthritis.
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis [Phase 1]
A Phase 1 study evaluating safety, tolerability, and preliminary efficacy of Si-544 in adults with psoriasis vulgaris or psoriatic arthritis…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Ten-Year Biologic Drug Survival in Psoriasis: Role of Genetic and Cardiometabolic Predictors
A completed clinical study evaluating ten-year persistence of biologic therapies in psoriasis and psoriatic arthritis and how genetic and ca…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Golimumab Safety and Surveillance Program Using the Ingenix NHI Database
This document reports the completion of a safety surveillance trial for golimumab using the Ingenix NHI database to monitor safety in rheuma…
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)
Pfizer's infliximab biosimilar was studied in a Drug Use Investigation for psoriasis indications; the trial has completed and results were p…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study
Results from a UK matched-cohort study examine the risk of venous thromboembolism among people with systemic inflammatory disorders. The tri…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Special Drug Use-results Survey to Evaluate Safety and Efficacy of Cosentyx in Pediatric Patients With PsV, PsA, or GPP
Special-use survey results assess the safety and efficacy of Cosentyx (secukinumab) in pediatric patients with psoriasis vulgaris, psoriatic…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Psoriatic Arthritis Study of Izokibep [Phase 2, Phase 3]
ACELYRIN's Phase 2/3 trial of izokibep for psoriatic arthritis was terminated, and the results have been posted. Details on efficacy and saf…
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Psoriatic Arthritis Research Collaborative: Biologic Sub-Study
A completed Biologic Sub-Study in the Psoriatic Arthritis Research Collaborative, sponsored by the University of Pennsylvania; results were …
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: COVID-19 VaccinE Response in Rheumatology Patients [Phase 4]
Phase 4 trial evaluating the COVID-19 vaccine response in patients with rheumatic diseases has completed, including rheumatoid arthritis, ps…
-
CLINICAL_TRIALS trial_result · 2025-04-13Clinical Trial Update: A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment [Phase 3]
A Phase 3 trial comparing deucravacitinib to placebo in active psoriatic arthritis patients (biologic-naïve or prior TNF inhibitor exposure)…
-
CLINICAL_TRIALS trial_result · 2025-04-01Clinical Trial Update: WORKWELL: Testing Work Advice for People With Arthritis [NA]
Update on the WORKWELL trial evaluating work advice for people with arthritis; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: A Study to Learn About the Study Medicine (Called Tofacitinib) in People With Psoriatic Arthritis
This clinical trial update reports the completion of a study evaluating tofacitinib in people with psoriatic arthritis, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic Arthritis [Phase 2]
Phase 2 clinical trial evaluating the impact of cannabis on pain and inflammation in rheumatoid arthritis and psoriatic arthritis. The study…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Serum, Cellular and Imaging Markers of Arthritis in Psoriasis Patients
A completed clinical trial investigating serum, cellular, and imaging biomarkers of arthritis in psoriasis patients.
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Quantitative Ultrasound of the Enthesis in Fibromyalgia and Psoriatic Arthritis
The clinical trial evaluating quantitative ultrasound of the enthesis in fibromyalgia and psoriatic arthritis has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: A Study of Guselkumab in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNF Alpha) Therapy [Phase 3]
Phase 3 study evaluating guselkumab in adults with active psoriatic arthritis and inadequate response to anti-TNF therapy has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: A Study to Characterize Profile of Participant With Psoriatic Arthritis Depending on Whether Their Disease is Managed by a Dermatologist or by a Rheumatologist, and Starting Ustekinumab
A completed clinical trial evaluating Psoriatic Arthritis patients starting ustekinumab and comparing profiles based on whether care was pro…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Diet Interventions in Psoriatic Arthritis [NA]
A completed clinical trial conducted by the University of Pennsylvania evaluated diet interventions for psoriatic arthritis.
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases [Phase 4]
Phase 4 clinical trial is currently enrolling by invitation to evaluate herpes zoster vaccination in patients with inflammatory rheumatic di…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA) [Phase 2]
A Phase 2 trial comparing VTX958 to placebo for active Psoriatic arthritis was terminated.
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: Study of the Effectiveness and Safety of SHR-1314 for Psoriatic Arthritis [Phase 2]
An update on a Phase 2 trial evaluating the effectiveness and safety of SHR-1314 in psoriatic arthritis. The study is reported as completed.